FDA approves scPharmaceuticals’ Furoscix sNDA for oedema in CKD
The US FDA has approved scPharmaceuticals’ sNDA for Furoscix, expanding its indication to include oedema treatment…
FDA approves scPharmaceuticals’ Furoscix sNDA for oedema in CKD
The US FDA has approved scPharmaceuticals’ sNDA for Furoscix, expanding its indication to include oedema treatment…
Pfizer appoints former J&J executive to lead obesity drug development – Reuters
Pfizer appoints former J&J executive to lead obesity drug development Reuters
Does ‘Oatzempic’ Help You Lose Weight? – Verywell Health
Does ‘Oatzempic’ Help You Lose Weight? Verywell Health
Industry Voices—The GLP-1 status quo is no longer acceptable, but it is changeable. – Fierce healthcare
Industry Voices—The GLP-1 status quo is no longer acceptable, but it is changeable. Fierce healthcare
The rise of the Ozempic menu and how weight-loss drugs are changing dining out – The Independent
The rise of the Ozempic menu and how weight-loss drugs are changing dining out The Independent
Weight loss drugs like Ozempic a boon for Streeterville plastic surgery clinic, boosting demand for facelifts – Chicago Sun-Times
Weight loss drugs like Ozempic a boon for Streeterville plastic surgery clinic, boosting demand for facelifts Chicago…
Is your weight loss drug affecting your relationship? – The Indian Express
Is your weight loss drug affecting your relationship? The Indian Express
The trillion-dollar opportunity in women’s health
Closing the gap in health interventions between men and women could add $1tn to the global…
FDA ODD given to Plus Therapeutics’ injectable radiotherapy
The FDA has granted orphan drug designation to Plus Therapeutics’ injectable radiotherapy, Rhenium (186Re) Obisbemeda.